Endoglin (CD105) and Vascular Endothelial Growth Factor as Prognostic Markers in Prostatic Adenocarcinoma

Yasser El-Gohary; Jan Silverman; Peter Olson; Yulin Liu; Jeffrey Cohen; Ralph Miller; Reda Saad
April 2007
American Journal of Clinical Pathology;Apr2007, Vol. 127 Issue 4, p572
Academic Journal
We studied endoglin and vascular endothelial growth factor (VEGF) expression as prognostic markers in prostatic adenocarcinoma in 50 radical prostatectomy specimens. Cases were further categorized by Gleason score as follows: 8 to 10, 9 cases; 7(4 + 3), 9 cases; 7 (3 + 4), 14 cases; 6, 13 cases; and 4 or 5, 5 cases. All cases were immunostained for endoglin, CD31, and VEGF. Positively stained microvessels were counted in densely vascular foci in a x 400 field. VEGF staining intensity was scored on a 2-tiered scale. Results were correlated with survival and other parameters. Endoglin demonstrated significantly more microvessels than did CD31 (mean ± SD, 37 ± 15 vs 22 ± 17; P < .001). VEGF expression was low in 21 cases (42%) and high in 29 (58%). Endoglin correlated positively with Gleason score, lymph node metastases, tumor stage, and preoperative prostate-specific antigen level (P < .05) but not with CD31. VEGF correlated significantly with angiolymphatic invasion and Gleason score (P < .05). A high endoglin microvessel count and VEGF expression correlated with shorter survival. Endoglin is a more specific and sensitive marker for tumor angiogenesis than CD31 and may serve as a prognostic marker for prostatic adenocarcinoma.


Related Articles

  • ANALYSIS OF VEGF GENE POLYMORPHISMS IN PANCREATIC ADENOCARCINOMA AND CHRONIC PANCREATITIS. Talar-Wojnarowska, Renata; Gąsiorowska, Anita; Smolarz, Beata; Romanowicz--Makowska, Hanna; Kulig, Andrzej; Małecka-Panas, Ewa // Polish Surgery / Chirurgia Polska;2006 Supplement, Vol. 8, p10 

    Background: Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis, necessary for microvasculature development and important for the growth and spread of pancreatic tumors. Methods: VEGF gene polymorphisms at position C-460T and G+405C were evaluated in 22 patients with...

  • Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Yu-Hong Li; Chun-Fang Hu; Qiong Shao; Ma-Yan Huang; Jing-Hui Hou; Dan Xie; Yi-Xin Zeng; Jian-Yong Shao // Journal of Translational Medicine;2008, Vol. 6, Special section p1 

    Background: Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in southern China. The China 1992 TNM staging system has been widely used for prognosis prediction of NPC patients in China. Although NPC patients can be classified according to their clinical stage in this system,...

  • Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix. Singh, Ashok K.; Gudehithlu, Krishnamurthy P.; Pegoraro, Alfredo A.; Singh, Gogi K.; Basheerudin, Khaja; Robey, Robert B.; Arruda, Jose A. L.; Dunea, George // Laboratory Investigation (00236837);May2004, Vol. 84 Issue 5, p597 

    We studied the effect of a high glucose (HG) environment on the vascular factors that are secreted by mesangial cells, and regulate endothelial growth and mesangial matrix deposition. To this effect, we measured the vascular factors in the glomeruli of streptozotocin-induced diabetic kidneys and...

  • Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Mura, M; Swain, R K; Zhuang, X; Vorschmitt, H; Reynolds, G; Durant, S; Beesley, J F J; Herbert, J M J; Sheldon, H; Andre, M; Sanderson, S; Glen, K; Luu, N-T; McGettrick, H M; Antczak, P; Falciani, F; Nash, G B; Nagy, Z S; Bicknell, R // Oncogene;1/19/2012, Vol. 31 Issue 3, p293 

    Tumor endothelial markers (TEMs) that are highly expressed in human tumor vasculature compared with vasculature in normal tissue hold clear therapeutic potential. We report that the C-type lectin CLEC14A is a novel TEM. Immunohistochemical and immunofluorescence staining of tissue arrays has...

  • Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study. Rastogi, Shishir; Kumar, Ramakant; Sankineani, Sukesh; Marimuthu, Kanniraj; Rijal, Laxman; Prakash, Shyam; Jalan, Divesh; Khan, Shah; Sharma, Mehar // International Orthopaedics;Nov2012, Vol. 36 Issue 11, p2315 

    Purpose: A prospective study was undertaken to evaluate the diagnostic and prognostic significance of serum levels of vascular endothelial growth factor (VEGF) in patients with primary localised osteosarcoma. Methods: Serum VEGF levels were measured by an enzyme-linked immunosorbent assay...

  • Can tumor location predict effectiveness of bevacizumab conducted in the first-line setting for metastatic colorectal cancer. You, K. Y.; Gao, Y. H. // Annals of Oncology;Feb2014, Vol. 25 Issue 2, p545 

    Explanation by Boisen et al. for tumor location as a marker for use of bevacizumab may not be tenable since expression level of VEGF-A could not predict effectiveness of bevacizumab. Besides, the study method by Boisen et al. seems to be inappropriate. More evidence is warranted before tumor...

  • Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro. Ki, M K; Jeoung, M H; Choi, J R; Rho, S-S; Kwon, Y-G; Shim, H; Chung, J; Hong, H J; Song, B D; Lee, S // Oncogene;11/28/2013, Vol. 32 Issue 48, p5449 

    It has been suggested that clec14a may be involved in tumor angiogenesis. However, a molecular mechanism has not been clearly identified. In this study, we show for the first time that C-type lectin-like domain (CTLD) of clec14a may be important for regulating cell migration and filopodia...

  • Serum vascular endothelial growth factor-A levels during induction therapy in children with acute lymphoblastic leukemia. Kalra, Manas; Dinand, Veronique; Choudhary, Sangeeta; Sachdeva, Anupam; Yadav, Satya // Indian Pediatrics;Jul2013, Vol. 50 Issue 7, p659 

    Objective: To evaluate serum vascular endothelial growth factor (VEGF) levels in children with acute lymphoblastic leukemia (ALL) during the induction phase of chemotherapy. Design: Prospective sudy. Setting: Hospital-based study over 18 months. Patients: 30 children with ALL and 17 healthy age-...

  • Markers of angiogenesis breast cancer. Kiluk, John; Carter, W. Bradford // MLO: Medical Laboratory Observer;Aug2006, Vol. 38 Issue 8, p10 

    The article evaluates some of the angiogenic tumor markers in breast cancer. It also talks about the process of angiogenesis and its role in cancer pathology. The markers discussed include vascular endothelial growth factor (VEGF), circulating endothelial cells (CEC), and endostatin. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics